Clinical Trial

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study aimed to compare the efficacy and safety of dual and quadruple regimens with different durations (7-day, 10-day, 14-day) for the eradication of Helicobacter pylori. Subjects were randomized to receive the intervention and were reviewed by 13C-urea breath test after 6 weeks. The eradication rates, adverse reaction rates and patient adherence were calculated.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-04.
Status change: Not Yet Recruiting → Recruiting 2024-12-10
Trial Details
NCT Number NCT06723197
Lead Sponsor Shandong University
Collaborators: Zibo Maternal and Child Health Hospital, Zaozhuang Municipal Hospital, Feicheng Municipal People's Hospital, Shandong University of Traditional Chinese Medicine, The People's Hospital of Jimo.Qingdao, Dezhou Hospital Qilu Hospital of Shandong University
Conditions HELICOBACTER PYLORI INFECTIONS
Enrollment 330 participants
Start Date 2024-12-10
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-11